Simon Wigglesworth, deputy chief executive at Epilepsy Action, said: “This is very disappointing news for the families who have spent so long waiting for the case to come to trial. This is not the first time the Legal Services Commission has withdrawn funding for this group of claimants. It was our understanding that they recommitted the funding in 2008 and that the case would get to trial.
National charity Epilepsy Action has today expressed delight and relief at the government’s announcement that plans for generic substitution of drugs are to be dropped.
The charity campaigned nationally for anti-epileptic drugs (AEDs) to be excluded from the Pharmaceutical Price Regulation Scheme (2009). Under the scheme, pharmacists would have been expected to automatically substitute a generic version of a prescribed drug where a branded drug is named on the prescription.
National charity Epilepsy Action has chosen Blackpool North and Cleveleys MP Paul Maynard as one of its vice-presidents.
Paul has epilepsy and knows first-hand how it can affect the lives of people with the condition.